These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 20727958

  • 41. Stereospecific pharmacokinetics of free and protein-bound ketoprofen in serum and synovial fluid of horses after intravenous and intramuscular administration.
    Brink P, DeGraves F, Ravis WR, Johansen D, Campbell JD, Duran SH.
    Am J Vet Res; 1998 Jun; 59(6):739-43. PubMed ID: 9622744
    [Abstract] [Full Text] [Related]

  • 42. Inversion of (R)- to (S)-ketoprofen in eight animal species.
    Aberg G, Ciofalo VB, Pendleton RG, Ray G, Weddle D.
    Chirality; 1995 Jun; 7(5):383-7. PubMed ID: 7495642
    [Abstract] [Full Text] [Related]

  • 43. Human LAT1 single nucleotide polymorphism N230K does not alter phenylalanine transport.
    Boado RJ, Li JY, Wise P, Pardridge WM.
    Mol Genet Metab; 2004 Dec; 83(4):306-11. PubMed ID: 15589117
    [Abstract] [Full Text] [Related]

  • 44. Stable incorporation of a lipophilic daunorubicin prodrug into apolipoprotein E-exposing liposomes induces uptake of prodrug via low-density lipoprotein receptor in vivo.
    Versluis AJ, Rump ET, Rensen PC, van Berkel TJ, Bijsterbosch MK.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):1-7. PubMed ID: 10086980
    [Abstract] [Full Text] [Related]

  • 45. Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide], in the rat.
    Bourasset F, Bernard K, Muñoz C, Genissel P, Scherrmann JM.
    Drug Metab Dispos; 2005 Aug; 33(8):1137-43. PubMed ID: 15860654
    [Abstract] [Full Text] [Related]

  • 46. Design, synthesis and biological evaluation of brain-specific glucosyl thiamine disulfide prodrugs of naproxen.
    Fan W, Wu Y, Li XK, Yao N, Li X, Yu YG, Hai L.
    Eur J Med Chem; 2011 Sep; 46(9):3651-61. PubMed ID: 21641697
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. The blood-brain barrier sodium-dependent multivitamin transporter: a molecular functional in vitro-in situ correlation.
    Park S, Sinko PJ.
    Drug Metab Dispos; 2005 Oct; 33(10):1547-54. PubMed ID: 16033951
    [Abstract] [Full Text] [Related]

  • 49. Functional involvement of rat organic anion transporter 2 (Slc22a7) in the hepatic uptake of the nonsteroidal anti-inflammatory drug ketoprofen.
    Morita N, Kusuhara H, Nozaki Y, Endou H, Sugiyama Y.
    Drug Metab Dispos; 2005 Aug; 33(8):1151-7. PubMed ID: 15900017
    [Abstract] [Full Text] [Related]

  • 50. Identification of human, rat and mouse hydrolyzing enzymes bioconverting amino acid ester prodrug of ketoprofen.
    Huttunen KM.
    Bioorg Chem; 2018 Dec; 81():494-503. PubMed ID: 30243240
    [Abstract] [Full Text] [Related]

  • 51. Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies.
    Na M, Yiyun C, Tongwen X, Yang D, Xiaomin W, Zhenwei L, Zhichao C, Guanyi H, Yunyu S, Longping W.
    Eur J Med Chem; 2006 May; 41(5):670-4. PubMed ID: 16527374
    [Abstract] [Full Text] [Related]

  • 52. Functional activity of a large neutral amino acid transporter (LAT) in rabbit retina: a study involving the in vivo retinal uptake and vitreal pharmacokinetics of L-phenyl alanine.
    Atluri H, Talluri RS, Mitra AK.
    Int J Pharm; 2008 Jan 22; 347(1-2):23-30. PubMed ID: 17686592
    [Abstract] [Full Text] [Related]

  • 53. Rapid in vivo dissolution of ketoprofen: implications on the biopharmaceutics classification system.
    Granero GE, Ramachandran C, Amidon GL.
    Pharmazie; 2006 Aug 22; 61(8):673-6. PubMed ID: 16964708
    [Abstract] [Full Text] [Related]

  • 54. Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain.
    Cornford EM, Young D, Paxton JW, Finlay GJ, Wilson WR, Pardridge WM.
    Cancer Res; 1992 Jan 01; 52(1):138-43. PubMed ID: 1727374
    [Abstract] [Full Text] [Related]

  • 55. Functional characterisation of novel analgesic product based on self-regulating drug carriers.
    Cevc G, Vierl U, Mazgareanu S.
    Int J Pharm; 2008 Aug 06; 360(1-2):18-28. PubMed ID: 18524509
    [Abstract] [Full Text] [Related]

  • 56. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
    Kobayashi K, Ohnishi A, Promsuk J, Shimizu S, Kanai Y, Shiokawa Y, Nagane M.
    Neurosurgery; 2008 Feb 06; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
    [Abstract] [Full Text] [Related]

  • 57. L-Type amino acid transporter 1 (lat1)-mediated targeted delivery of perforin inhibitors.
    Huttunen KM, Huttunen J, Aufderhaar I, Gynther M, Denny WA, Spicer JA.
    Int J Pharm; 2016 Feb 10; 498(1-2):205-16. PubMed ID: 26705152
    [Abstract] [Full Text] [Related]

  • 58. Improving the direct penetration into tissues underneath the skin with iontophoresis delivery of a ketoprofen cationic prodrug.
    Lobo S, Yan G.
    Int J Pharm; 2018 Jan 15; 535(1-2):228-236. PubMed ID: 29104055
    [Abstract] [Full Text] [Related]

  • 59. Physicochemical compatibility between ketoprofen lysine salt injections (Artrosilene) and pharmaceutical products frequently used for combined therapy by intravenous administration.
    Anacardio R, Perilli O, Bartolini S, Gentile MM, Mazzeo P, Carlucci G.
    J Pharm Biomed Anal; 2003 Aug 21; 32(6):1235-41. PubMed ID: 12907268
    [Abstract] [Full Text] [Related]

  • 60. Biocatalytic synthesis and in vitro release of biodegradable linear polyesters with pendant ketoprofen.
    Wang HY, Zhang WW, Wang N, Li C, Li K, Yu XQ.
    Biomacromolecules; 2010 Dec 13; 11(12):3290-3. PubMed ID: 21053944
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.